• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经退行性疾病中致病性蛋白的细胞间传递。

Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases.

机构信息

Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

出版信息

Nat Med. 2014 Feb;20(2):130-8. doi: 10.1038/nm.3457.

DOI:10.1038/nm.3457
PMID:24504409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4011661/
Abstract

A common feature of many neurodegenerative diseases is the deposition of β-sheet-rich amyloid aggregates formed by proteins specific to these diseases. These protein aggregates are thought to cause neuronal dysfunction, directly or indirectly. Recent studies have strongly implicated cell-to-cell transmission of misfolded proteins as a common mechanism for the onset and progression of various neurodegenerative disorders. Emerging evidence also suggests the presence of conformationally diverse 'strains' of each type of disease protein, which may be another shared feature of amyloid aggregates, accounting for the tremendous heterogeneity within each type of neurodegenerative disease. Although there are many more questions to be answered, these studies have opened up new avenues for therapeutic interventions in neurodegenerative disorders.

摘要

许多神经退行性疾病的一个共同特征是由这些疾病特有的蛋白质组成的富含β-折叠的淀粉样聚集物的沉积。这些蛋白质聚集物被认为直接或间接地导致神经元功能障碍。最近的研究强烈表明,错误折叠蛋白的细胞间传递是各种神经退行性疾病发病和进展的共同机制。新出现的证据还表明,每种疾病蛋白都存在构象多样的“菌株”,这可能是淀粉样聚集物的另一个共同特征,这解释了每种神经退行性疾病中存在的巨大异质性。尽管还有许多问题需要回答,但这些研究为神经退行性疾病的治疗干预开辟了新的途径。

相似文献

1
Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases.神经退行性疾病中致病性蛋白的细胞间传递。
Nat Med. 2014 Feb;20(2):130-8. doi: 10.1038/nm.3457.
2
[Proteinopathies--forms of neurodegenerative disorders with protein aggregation-based pathology].[蛋白质病——基于蛋白质聚集病理的神经退行性疾病形式]
Mol Biol (Mosk). 2012 May-Jun;46(3):402-15.
3
Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.改善蛋白质错误折叠神经退行性疾病的潜在机制和化学/生化治疗方法。
Biofactors. 2017 Nov;43(6):737-759. doi: 10.1002/biof.1264. Epub 2016 Feb 22.
4
Inhibition of aggregate formation as therapeutic target in protein misfolding diseases: effect of tetracycline and trehalose.抑制聚集物形成作为蛋白质错误折叠疾病的治疗靶点:四环素和海藻糖的作用。
Expert Opin Ther Targets. 2010 Dec;14(12):1311-21. doi: 10.1517/14728222.2010.531012.
5
The role of amyloidogenic protein oligomerization in neurodegenerative disease.淀粉样蛋白原纤维聚集在神经退行性疾病中的作用。
J Mol Med (Berl). 2013 Jun;91(6):653-64. doi: 10.1007/s00109-013-1025-1. Epub 2013 Mar 27.
6
Prion-like spread of protein aggregates in neurodegeneration.蛋白聚集物的朊病毒样传播在神经退行性变中的作用。
J Exp Med. 2012 May 7;209(5):889-93. doi: 10.1084/jem.20120741.
7
Viewing Extrinsic Proteotoxic Stress Through the Lens of Amyloid Cardiomyopathy.从淀粉样心肌病视角看外在蛋白毒性应激
Physiology (Bethesda). 2016 Jul;31(4):294-9. doi: 10.1152/physiol.00047.2015.
8
[Amyloid aggregates: role in Protein Misfolding Disorders].[淀粉样蛋白聚集体:在蛋白质错误折叠疾病中的作用]
Rev Med Chil. 2013 Apr;141(4):495-505. doi: 10.4067/S0034-98872013000400011.
9
Nucleic acid aptamers for neurodegenerative diseases.核酸适体在神经退行性疾病中的应用。
Biochimie. 2018 Feb;145:73-83. doi: 10.1016/j.biochi.2017.10.026. Epub 2017 Nov 20.
10
Longitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative disease.活神经元中蛋白质稳态的纵向测量:决定神经退行性疾病模型中命运的特征。
FEBS Lett. 2013 Apr 17;587(8):1139-46. doi: 10.1016/j.febslet.2013.02.043. Epub 2013 Mar 1.

引用本文的文献

1
Small Extracellular Vesicles in Neurodegenerative Disease: Emerging Roles in Pathogenesis, Biomarker Discovery, and Therapy.神经退行性疾病中的细胞外小泡:在发病机制、生物标志物发现及治疗中的新作用
Int J Mol Sci. 2025 Jul 26;26(15):7246. doi: 10.3390/ijms26157246.
2
Design of Ig-like binders targeting α-synuclein fibril for mitigating its pathological activities.靶向α-突触核蛋白原纤维以减轻其病理活性的免疫球蛋白样结合物的设计。
Nat Commun. 2025 Aug 9;16(1):7368. doi: 10.1038/s41467-025-62755-1.
3
Network spreading and local biological vulnerability in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的网络传播与局部生物易损性
Commun Biol. 2025 Aug 4;8(1):1153. doi: 10.1038/s42003-025-08561-3.
4
Subregional analysis of the amygdala, thalamus, and hypothalamus at the pre-decline stage in Parkinson's disease with later cognitive impairment.帕金森病伴后期认知障碍患者衰退前期杏仁核、丘脑和下丘脑的亚区域分析。
Front Aging Neurosci. 2025 May 9;17:1588027. doi: 10.3389/fnagi.2025.1588027. eCollection 2025.
5
Hyperphosphorylated tau-based Alzheimer's Disease drug discovery: Identification of inhibitors of tau aggregation and cytotoxicity.基于过度磷酸化tau蛋白的阿尔茨海默病药物研发:tau蛋白聚集和细胞毒性抑制剂的鉴定
SLAS Discov. 2025 Jun;33:100235. doi: 10.1016/j.slasd.2025.100235. Epub 2025 May 3.
6
Neural-induced human adipose tissue-derived stem cell secretome exerts neuroprotection against rotenone-induced Parkinson's disease in rats.神经诱导的人脂肪组织来源干细胞分泌组对大鼠鱼藤酮诱导的帕金森病具有神经保护作用。
Stem Cell Res Ther. 2025 Apr 20;16(1):193. doi: 10.1186/s13287-025-04306-5.
7
α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies.α-突触核蛋白与tau蛋白:相互作用、交叉播种以及将突触核蛋白病重新定义为复杂蛋白质病
Front Neurosci. 2025 Mar 27;19:1570553. doi: 10.3389/fnins.2025.1570553. eCollection 2025.
8
Network-based Molecular Constraints on Synaptic Density Alterations in Schizophrenia.基于网络的精神分裂症突触密度改变的分子制约因素
medRxiv. 2025 Mar 23:2025.03.22.25324465. doi: 10.1101/2025.03.22.25324465.
9
Design and Development of a Novel BET Protein-Targeted PET Imaging Probe for In Vivo Characterization of Alzheimer's Disease Pathophysiology.用于体内表征阿尔茨海默病病理生理学的新型BET蛋白靶向PET成像探针的设计与开发
J Med Chem. 2025 Apr 10;68(7):7605-7614. doi: 10.1021/acs.jmedchem.5c00068. Epub 2025 Mar 21.
10
[Quercetin mitigates HIV-1 gp120-induced rat astrocyte neurotoxicity promoting G3BP1 disassembly in stress granules].[槲皮素减轻HIV-1 gp120诱导的大鼠星形胶质细胞神经毒性并促进应激颗粒中G3BP1的解离]
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Feb 20;45(2):304-312. doi: 10.12122/j.issn.1673-4254.2025.02.11.

本文引用的文献

1
Molecular structure of β-amyloid fibrils in Alzheimer's disease brain tissue.阿尔茨海默病脑组织中β-淀粉样纤维的分子结构。
Cell. 2013 Sep 12;154(6):1257-68. doi: 10.1016/j.cell.2013.08.035.
2
Conformational features of tau fibrils from Alzheimer's disease brain are faithfully propagated by unmodified recombinant protein.阿尔茨海默病脑中的 tau 纤维的构象特征通过未修饰的重组蛋白被真实地传递。
Biochemistry. 2013 Oct 8;52(40):6960-7. doi: 10.1021/bi400866w. Epub 2013 Sep 27.
3
Seeded strain-like transmission of β-amyloid morphotypes in APP transgenic mice.β-淀粉样蛋白形态在 APP 转基因小鼠中的种系样传播。
EMBO Rep. 2013 Nov;14(11):1017-22. doi: 10.1038/embor.2013.137. Epub 2013 Sep 3.
4
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds.硫酸乙酰肝素蛋白聚糖介导特定蛋白构象种子的内化和传播。
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):E3138-47. doi: 10.1073/pnas.1301440110. Epub 2013 Jul 29.
5
Prion-like properties of pathological TDP-43 aggregates from diseased brains.病理性 TDP-43 聚集物的朊病毒样特性源自病变大脑。
Cell Rep. 2013 Jul 11;4(1):124-34. doi: 10.1016/j.celrep.2013.06.007. Epub 2013 Jul 3.
6
Distinct α-synuclein strains differentially promote tau inclusions in neurons.不同的 α-突触核蛋白菌株在神经元中差异性地促进 tau 包涵体的形成。
Cell. 2013 Jul 3;154(1):103-17. doi: 10.1016/j.cell.2013.05.057.
7
Caudo-rostral brain spreading of α-synuclein through vagal connections.α-突触核蛋白通过迷走神经连接的头尾向脑扩散。
EMBO Mol Med. 2013 Jul;5(7):1119-27. doi: 10.1002/emmm.201302475. Epub 2013 May 23.
8
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism.β淀粉样蛋白 42 聚集物的增殖通过二级成核机制发生。
Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9758-63. doi: 10.1073/pnas.1218402110. Epub 2013 May 23.
9
Brain homogenates from human tauopathies induce tau inclusions in mouse brain.人脑匀浆可诱导鼠脑形成 tau 包涵体。
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9535-40. doi: 10.1073/pnas.1301175110. Epub 2013 May 20.
10
Stages of pTDP-43 pathology in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中 pTDP-43 病理学的阶段。
Ann Neurol. 2013 Jul;74(1):20-38. doi: 10.1002/ana.23937. Epub 2013 Jun 19.